---
schema_version: "secwatch.filing_event.v1"
accession: "0001757898-25-000011"
form_type: "8-K"
ticker: "STE"
cik: "0001757898"
company_name: "STERIS plc"
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:20:57.742128+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# STERIS Q2 FY2026 revenue up 10% to $1.5B; adjusted EPS $2.47; raises FY outlook

## Summary
- Q2 revenue $1.5B (+10% YoY); constant currency organic revenue +9%.
- As-reported EPS $1.94; adjusted EPS $2.47 versus $2.14 last year.
- Healthcare revenue +9%, AST +10%, Life Sciences +13% (all as reported).
- FY2026 adjusted EPS guidance raised to $10.15-$10.30 (prior $9.90-$10.15).
- Free cash flow outlook increased to ~$850M; tariff impact unchanged at ~$45M pretax.

## SEC filing metadata
- accession: 0001757898-25-000011
- form_type: 8-K
- ticker: STE
- cik: 0001757898
- company_name: STERIS plc
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757898/000175789825000011/0001757898-25-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757898/000175789825000011/ste-20251105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001757898-25-000011
- JSON: https://secwatch.observer/filing/0001757898-25-000011.json
- Plain text: https://secwatch.observer/filing/0001757898-25-000011.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.